Sugen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 3.24 M
as on 08-12-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.62 Cr
as on 08-12-2024
- Satisfied Charges ₹ 3.00 Cr
as on 08-12-2024
- Revenue -8.17%
(FY 2023)
- Profit -35.64%
(FY 2023)
- Ebitda -0.69%
(FY 2023)
- Net Worth 12.76%
(FY 2023)
- Total Assets -3.95%
(FY 2023)
About Sugen Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.24 M.
The company currently has active open charges totaling ₹2.62 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vikram Varanasi, Chilakapati Reddy, and Damodar Reddy serve as directors at the Company.
- CIN/LLPIN
U24230AP2005PTC045939
- Company No.
045939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Chittoor, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sugen Life Sciences Private Limited offer?
Sugen Life Sciences Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Anti Bacterial & Fungal Extracts, Computer, IT & Software Training, Computer Education, Graduation & High Education Programs, Medical Educational Service, Medical Consultants & Clinics, Medical Consultancy Services, Material Testing Labs & Services, Laboratory Testing Services.
Who are the key members and board of directors at Sugen Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram Varanasi  | Director | 12-Oct-2005 | Current |
| Chilakapati Reddy | Director | 20-Apr-2005 | Current |
| Damodar Reddy | Director | 04-May-2005 | Current |
Financial Performance and Corporate Structure Insights of Sugen Life Sciences.
Sugen Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.17% decrease. The company also saw a substantial fall in profitability, with a 35.64% decrease in profit. The company's net worth Soared by an impressive increase of 12.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sugen Life Sciences?
Unlock access to Sugen Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Naturo Food And Fruit Products Private LimitedActive 38 years 1 monthVikram Varanasi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Biotechnology Industry Research Assistance Council Creation Date: 10 Jul 2012 | ₹2.62 Cr | Open |
Andhra Pradesh State Financial Corporation Creation Date: 16 Jul 2009 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Sugen Life Sciences?
Unlock and access historical data on people associated with Sugen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sugen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sugen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
